ClinicalTrials.Veeva

Menu

Pelvic Floor Muscle Activity in Primary Dysmenorrhea

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Primary Dysmenorrhea

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06803173
P.T.REC/012/005371

Details and patient eligibility

About

This study will be conducted to assess the pelvic floor muscle (PFM) activity in primary dysmenorrhea (PD).

Full description

Dysmenorrhea, marked by painful menstrual cramps, often involves increased PFM tension, spasms, and inflammation, affecting females' quality of life and productivity. The traditional focus has been on investigating the abdominal region in women with PD. However, this new perspective considers that the hormonal changes experienced during the menstrual cycle in PD patients may lead to a heightened sensitivity of the PFM, not just the abdominal area. This suggests that the pain associated with PD may have a more widespread impact on the pelvic region rather than being localized to the abdomen. Pelvic floor myofascial trigger points (MTrPs) may also exacerbate menstrual pain through the neural pathway.

There is a critical gap in the literature regarding the nature of the association between dysmenorrhea and PFM activity in this population. Yet, it is unknown whether the pain is a cause or result of increased PFM tone, and the nature of the association between menstrual pain and PFM tone in women with PD is also unknown.

So, this study utilizes transabdominal ultrasound (TAU) to examine PFM activity in PD, aiming to clarify how PFM activity contributes to menstrual pain. Understanding these dynamics could lead to preventive strategies and educational efforts highlighting the role of pelvic floor interventions in managing dysmenorrhea, potentially improving treatment methods and overall women's health management.

Enrollment

77 estimated patients

Sex

Female

Ages

19 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • They should be virgin, healthy female physiotherapy students with PD.
  • They have regular menstruation (3-8 days in duration, with 21-35 days in between).
  • Their ages will range from 18 to 25 years old.
  • Their body mass index (BMI) will range from 18 to 24.9 kg/m2.
  • Their waist-to-hip ratio will be less than 0.8.

Exclusion criteria

  • Any urological or gynecological disorders in the previous 12 weeks (e.g., endometriosis, fibroids).
  • Fibromyalgia.
  • Severe psychiatric or psychological disorders.
  • Those who had taken analgesics in the 12 hours before the assessment.
  • Abdominal or pelvic surgery within the past six months.

Trial design

77 participants in 3 patient groups

group of mild primary dysmenorrhea
Description:
It will consist of 26 females with mild dysmenorrhea (WaLIDD score =1-4)
Treatment:
Other: No intervention
group of moderate primary dysmenorrhea
Description:
It will consist of 26 females with moderate dysmenorrhea (WaLIDD score =5-7)
Treatment:
Other: No intervention
group of severe primary dysmenorrhea
Description:
It will consist of 26 females with severe dysmenorrhea (WaLIDD score =8-12)
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Wafaa AM Abdelraouf, B.Sc.; Amira Nagy Abdellatif, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems